6-Methyl-1H-indazole-3-carboxylic acid is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting enzyme inhibition and receptor modulation. Its structural framework is often incorporated into molecules designed for anti-inflammatory, anticancer, and antimicrobial applications. Additionally, it is explored in the development of novel therapeutic agents due to its potential to interact with specific biological pathways. Researchers also use it to study structure-activity relationships in drug discovery, aiming to optimize efficacy and reduce side effects in new medications.